Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Galectin-3 for Success of Respiratory Weaning

NCT05054556 is registered in ClinicalTrials.gov with Asklepios Neurological Clinic Bad Salzhausen as lead sponsor.

NCT NCT05054556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05054556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Galectin-3 for Success of Respiratory Weaning
Lead sponsor
Asklepios Neurological Clinic Bad Salzhausen
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
June 30, 2025
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

galectin-3 during respiratory weaning